Profile data is unavailable for this security.
About the company
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
- Revenue in USD (TTM)196.03m
- Net income in USD-54.75m
- Incorporated2014
- Employees516.00
- LocationTreace Medical Concepts Inc100 Palmetto Park PlacePONTE VEDRA 32081United StatesUSA
- Phone+1 (904) 373-5940
- Fax+1 (904) 834-7169
- Websitehttps://www.treace.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stereotaxis Inc | 26.77m | -22.06m | 179.86m | 122.00 | -- | 10.85 | -- | 6.72 | -0.2737 | -0.2737 | 0.3318 | 0.2708 | 0.5617 | 1.46 | 6.01 | 219,434.40 | -43.46 | -25.02 | -61.11 | -34.12 | 55.51 | 67.57 | -77.37 | -41.90 | 1.88 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Inogen Inc | 315.66m | -102.45m | 204.62m | 834.00 | -- | 0.9897 | -- | 0.6482 | -4.42 | -4.42 | 13.62 | 8.78 | 0.8634 | 6.76 | 6.01 | 378,489.20 | -28.02 | -8.23 | -34.53 | -9.53 | 40.14 | 44.54 | -32.46 | -10.31 | 2.56 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Butterfly Network Inc | 68.08m | -121.92m | 205.44m | 225.00 | -- | 1.01 | -- | 3.02 | -0.5893 | -0.5893 | 0.329 | 0.9685 | 0.2045 | 0.6954 | 4.97 | 302,577.80 | -36.61 | -- | -42.07 | -- | 26.50 | -- | -179.08 | -- | 3.34 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Akoya Biosciences Inc | 96.63m | -63.32m | 221.05m | 330.00 | -- | 4.09 | -- | 2.29 | -1.48 | -1.48 | 2.18 | 1.09 | 0.5423 | 2.49 | 7.23 | 292,827.30 | -35.53 | -- | -44.59 | -- | 58.27 | -- | -65.53 | -- | 2.94 | -10.94 | 0.5882 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Neuropace Inc | 65.42m | -32.96m | 228.90m | 171.00 | -- | 10.74 | -- | 3.50 | -1.28 | -1.28 | 2.53 | 0.7423 | 0.590 | 1.65 | 6.61 | 382,578.90 | -29.72 | -- | -33.88 | -- | 73.56 | -- | -50.38 | -- | 5.02 | -4.97 | 0.7339 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| AngioDynamics, Inc. | 324.01m | -192.37m | 245.13m | 815.00 | -- | 1.13 | -- | 0.7566 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| Utah Medical Products, Inc. | 50.22m | 16.64m | 249.26m | 169.00 | 15.18 | 1.96 | 10.86 | 4.96 | 4.57 | 4.57 | 13.81 | 35.35 | 0.3873 | 2.19 | 11.25 | 297,183.40 | 12.83 | 12.69 | 13.38 | 13.19 | 59.81 | 61.57 | 33.12 | 30.51 | 20.53 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| Senseonics Holdings Inc | 22.39m | -60.39m | 255.43m | 132.00 | -- | 7.13 | -- | 11.41 | -0.1023 | -0.1023 | 0.0387 | 0.1385 | 0.1418 | 2.40 | 6.41 | 169,621.20 | -38.24 | -73.65 | -45.21 | -106.97 | 13.81 | -40.41 | -269.73 | -649.86 | 7.03 | -- | 0.3593 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| AxoGen Inc | 163.73m | -21.28m | 261.35m | 426.00 | -- | 2.80 | -- | 1.60 | -0.4943 | -0.4943 | 3.80 | 2.13 | 0.8709 | 1.49 | 7.04 | 384,333.30 | -11.32 | -13.92 | -12.82 | -15.84 | 78.34 | 79.74 | -13.00 | -20.28 | 2.23 | -8.76 | 0.3346 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Edap Tms SA (ADR) | 65.14m | -22.83m | 262.32m | 307.00 | -- | 4.27 | -- | 4.03 | -0.6173 | -0.6173 | 1.76 | 1.65 | 0.6272 | 2.68 | 3.86 | 212,188.50 | -21.98 | -6.62 | -29.54 | -9.22 | 40.40 | 43.23 | -35.05 | -9.59 | 2.30 | -27.44 | 0.1045 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Treace Medical Concepts Inc | 196.03m | -54.75m | 274.38m | 516.00 | -- | 2.17 | -- | 1.40 | -0.8885 | -0.8885 | 3.18 | 2.04 | 0.797 | 1.28 | 7.07 | 379,905.00 | -22.26 | -- | -25.98 | -- | 80.99 | -- | -27.93 | -- | 3.22 | -- | 0.2958 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| Sight Sciences Inc | 81.50m | -54.75m | 276.59m | 214.00 | -- | 2.52 | -- | 3.39 | -1.12 | -1.12 | 1.67 | 2.20 | 0.4628 | 1.66 | 5.09 | 380,822.40 | -31.09 | -38.78 | -33.65 | -42.20 | 85.73 | 80.74 | -67.18 | -105.14 | 12.42 | -14.76 | 0.2358 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Zynex Inc | 188.68m | 8.17m | 328.56m | 1.10k | 45.73 | 10.12 | 25.98 | 1.74 | 0.2261 | 0.2261 | 5.39 | 1.02 | 1.59 | 2.52 | 6.56 | 171,530.00 | 6.89 | 14.58 | 8.41 | 17.52 | 80.22 | 79.62 | 4.33 | 10.44 | 2.87 | 7.24 | 0.6381 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
| Tactile Systems Technology Inc | 276.67m | 28.19m | 333.82m | 992.00 | 11.88 | 1.73 | 9.61 | 1.21 | 1.18 | 1.18 | 11.70 | 8.14 | 1.01 | 6.77 | 6.05 | 278,896.20 | 10.30 | 0.9015 | 12.18 | 1.09 | 49.98 | 49.10 | 10.19 | 0.8309 | 3.63 | -- | 0.128 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Pulmonx Corp | 72.99m | -58.73m | 339.64m | 279.00 | -- | 3.07 | -- | 4.65 | -1.54 | -1.54 | 1.91 | 2.85 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
Data as of May 10 2024. Currency figures normalised to Treace Medical Concepts Inc's reporting currency: US Dollar USD
38.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 4.17m | 6.75% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 3.29m | 5.33% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 3.00m | 4.85% |
| William Blair Investment Management LLCas of 31 Dec 2023 | 2.87m | 4.64% |
| Armistice Capital LLCas of 31 Dec 2023 | 2.86m | 4.63% |
| Divisadero Street Capital Management LPas of 31 Dec 2023 | 1.75m | 2.83% |
| TimesSquare Capital Management LLCas of 31 Dec 2023 | 1.75m | 2.83% |
| CIBC Private Wealth Advisors, Inc.as of 31 Dec 2023 | 1.46m | 2.36% |
| Emerald Advisers LLCas of 31 Dec 2023 | 1.45m | 2.34% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.42m | 2.29% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
